Last reviewed · How we verify

NCT04173923

Long Term Follow-up of Cervical Myelopathy Inpatients Treated With Integrated Complementary and Alternative Medicine

Completed Last updated 10 August 2022
What this trial tests

trial testing Herbal medicine in Cervical Myelopathy in 40 participants. Completed in 19 November 2020.

Timeline
20 November 2018
Primary endpoint
19 November 2020
19 November 2020

Quick facts

Lead sponsorJaseng Medical Foundation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date20 November 2018
Primary completion19 November 2020
Estimated completion19 November 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Jaseng Medical Foundation

Who can join

Eligibility, any sex, with Cervical Myelopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Model of this study is a combined both retrospective chart review and follow up survey. Data of 4 hospitals will be used to find out the efficacy of conservative treatment in cervical myelopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Herbal medicine

Trials testing the same drug.

Other recruiting trials for Cervical Myelopathy

Currently open trials in the same condition.

Other Jaseng Medical Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04173923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing